Attri N, Das S, Banerjee J, Shamsuddin S, Dash S, Pramanik A
ACS Appl Bio Mater. 2024; 7(5):2677-2694.
PMID: 38613498
PMC: 11110070.
DOI: 10.1021/acsabm.4c00153.
Abdou R, Mojally M, Attia H, Dawoud M
Drug Deliv Transl Res. 2023; 13(10):2463-2474.
PMID: 37010791
DOI: 10.1007/s13346-023-01325-8.
Rajesh S, Zhai J, Drummond C, Tran N
Pharmaceutics. 2022; 14(10).
PMID: 36297610
PMC: 9609773.
DOI: 10.3390/pharmaceutics14102175.
Sultan A, El Nashar N, Ashmawy S, El Maghraby G
Int J Nanomedicine. 2022; 17:3543-3560.
PMID: 35983479
PMC: 9379123.
DOI: 10.2147/IJN.S370235.
Tella J, Adekoya J, Ajanaku K
R Soc Open Sci. 2022; 9(6):220013.
PMID: 35706676
PMC: 9174711.
DOI: 10.1098/rsos.220013.
Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
Chountoulesi M, Pispas S, Tseti I, Demetzos C
Pharmaceuticals (Basel). 2022; 15(4).
PMID: 35455426
PMC: 9028109.
DOI: 10.3390/ph15040429.
Inverse ISAsomes in Bio-Compatible Oils-Exploring Formulations in Squalane, Triolein and Olive Oil.
Trummer F, Glatter O, Chemelli A
Nanomaterials (Basel). 2022; 12(7).
PMID: 35407249
PMC: 9000821.
DOI: 10.3390/nano12071133.
Understanding the Impact of Age-Related Changes in Pediatric GI Solubility by Multivariate Data Analysis.
Guimaraes M, Maharaj A, Edginton A, Vertzoni M, Fotaki N
Pharmaceutics. 2022; 14(2).
PMID: 35214088
PMC: 8880315.
DOI: 10.3390/pharmaceutics14020356.
Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study.
Kaul S, Nagaich U, Verma N
Drug Deliv Transl Res. 2021; 12(7):1719-1737.
PMID: 34582029
DOI: 10.1007/s13346-021-01072-8.
Sunscreen Enhancement of Octyl Methoxycinnamate Microcapsules by Using Two Biopolymers as Wall Materials.
Xu C, Zeng X, Yang Z, Ji H
Polymers (Basel). 2021; 13(6).
PMID: 33799764
PMC: 8001204.
DOI: 10.3390/polym13060866.
Ion exchange column technique as a novel method for evaluating the release of docetaxel from different lipid nanoparticles.
Dawoud M, Abdou R
Drug Deliv Transl Res. 2021; 12(1):282-293.
PMID: 33768474
DOI: 10.1007/s13346-021-00937-2.
Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres.
Knoke S, Bunjes H
Pharmaceutics. 2021; 13(2).
PMID: 33525325
PMC: 7912624.
DOI: 10.3390/pharmaceutics13020173.
An overview of polymeric nano-biocomposites as targeted and controlled-release devices.
Rahim M, Haris M, Saqib N
Biophys Rev. 2020; 12(5):1223-1231.
PMID: 32901426
PMC: 7575665.
DOI: 10.1007/s12551-020-00750-0.
In Vitro Release Study of the Polymeric Drug Nanoparticles: Development and Validation of a Novel Method.
Weng J, Tong H, Chow S
Pharmaceutics. 2020; 12(8).
PMID: 32759786
PMC: 7465254.
DOI: 10.3390/pharmaceutics12080732.
Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells.
Zhang L, Li J, Tian D, Sun L, Wang X, Tian M
Cell Death Dis. 2020; 11(1):1.
PMID: 31911576
PMC: 6946659.
DOI: 10.1038/s41419-019-2182-0.
Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems.
Mircioiu C, Voicu V, Anuta V, Tudose A, Celia C, Paolino D
Pharmaceutics. 2019; 11(3).
PMID: 30901930
PMC: 6471682.
DOI: 10.3390/pharmaceutics11030140.
Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals.
Paolino D, Tudose A, Celia C, Di Marzio L, Cilurzo F, Mircioiu C
Materials (Basel). 2019; 12(5).
PMID: 30813650
PMC: 6427212.
DOI: 10.3390/ma12050693.
Cubosomes: The Next Generation of Smart Lipid Nanoparticles?.
Barriga H, Holme M, Stevens M
Angew Chem Int Ed Engl. 2018; 58(10):2958-2978.
PMID: 29926520
PMC: 6606436.
DOI: 10.1002/anie.201804067.
Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
Freag M, Elnaggar Y, Abdelmonsif D, Abdallah O
Int J Nanomedicine. 2016; 11:4799-4818.
PMID: 27703348
PMC: 5036603.
DOI: 10.2147/IJN.S111736.
Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.
Ling G, Zhang T, Zhang P, Sun J, He Z
Int J Nanomedicine. 2016; 11:4077-91.
PMID: 27601896
PMC: 5003557.
DOI: 10.2147/IJN.S95767.